Technische Universität Dresden

Characteristics and outcome of patients with low-/intermediate-risk acute promyelocytic leukemia treated with arsenic trioxide: an international collaborative (2021) Kayser S, Schlenk RF, Lebon D, Carre M, Goetze KS, Stoelzel F, Berceanu A, et al. Journal article Artificial extracellular matrices containing bioactive glass nanoparticles promote osteogenic differentiation in human mesenchymal stem cells (2021) Kroschwald LM, Allerdt F, Bernhardt A, Rother S, Zheng K, Maqsood I, Halfter N, et al. Journal article Correction to: Innovative radiation oncology Together—Precise, Personalized, Human: Vision 2030 for radiotherapy & radiation oncology in Germany (Strahlentherapie und Onkologie, (2021), 197, 12, (1043-1048), 10.1007/s00066-021-01843-9) (2021) Krug D, Hecht M, Ebert N, Maurer M, Fleischmann DF, Fokas E, Straube C, et al. Journal article, Erratum Outage prediction for ultra-reliable low-latency communications in fast fading channels (2021) Trassl A, Schmitt E, Hoessler T, Scheuvens L, Franchi N, Schwarzenberg N, Fettweis G Journal article Graphene Biodevices for Early Disease Diagnosis Based on Biomarker Detection (2021) Han Q, Pang J, Li Y, Sun B, Ibarlucea B, Liu X, Gemming T, et al. Journal article, Review article The Mixed-Valence Catena-Heteropolycation (Bi2S2)+ (2021) Knies M, Nawroth P, Golub P, Isaeva A, Ruck M Journal article Multicolor Patterning of 2D Semiconductor Nanoplatelets (2021) Khoshkhoo MS, Prudnikau A, Chashmejahanbin MR, Helbig R, Lesnyak V, Cuniberti G Journal article Characteristics and Outcome of Patients with Acute Myeloid Leukemia and Trisomy 4 (2021) Kayser S, Martinez-Cuadron D, Hanoun M, Stoelzel F, Gil C, Reinhardt HC, Aguiar E, et al. Conference contribution Real-World Experience of CPX-351 As First-Line Treatment in 188 Patients with Acute Myeloid Leukemia (2021) Rautenberg C, Stoelzel F, Roellig C, Stelljes M, Gaidzik V, Lauseker M, Kriege O, et al. Conference contribution Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021) Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al. Conference contribution